Bio-Techne Corp.

TECHNASDAQ • USD
ThemeBiotech - Drug Development›Clinical-Stage Platforms
53.18 USD
↗ 2.33 (4.58%)AT CLOSE (11:59 AM EDT)
53.07
↘ 0.12 (0.22%)
POST MARKET (AS OF 07:47 PM EDT)
Post Market
AS OF 07:47 PM EDT
53.07
↘ 0.12 (0.22%)
🔴Market: CLOSED
Open?$51.91
High?$53.30
Low?$51.34
Prev. Close?$50.85
Volume?4.2M
Avg. Volume?3.0M
VWAP?$52.56
Rel. Volume?1.38x
Bid / Ask
Bid?$49.57 × 100
Ask?$55.50 × 100
Spread?$5.93
Midpoint?$52.54
Valuation & Ratios
Market Cap?8.0B
Shares Out?156.6M
Float?154.8M
Float %?99.0%
P/E Ratio?72.67
P/B Ratio?3.82
EPS?$0.70
Dividend?0.63%
Ex-Dividend?N/A

Bio-Techne Corp. (TECH) trades at $53.25 per share. The stock presents a bullish profile across the board: both technical indicators and our fundamental models signal a "Buy" and "Buy" respectively. Key drivers include a robust Altman Z-Score and a bearish Death Cross on the long-term moving averages. Furthermore, TECH is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Jun 4, 2026.

News
Profile
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Themes
Biotech - Drug Development›Clinical-Stage PlatformsHealthcare - Genomics & Precision Medicine›Precision Medicine Platforms
Employees
3.1K
Market Cap
8.0B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.bio-techne.com
Listed
1989-05-08
Address
614 MCKINLEY PL N E
MINNEAPOLIS, MN 55413
Phone: 612-379-8854
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?
77
Z-Score?
100
Momentum?
75
Short Sent.?
55
Piotroski F-Score?6/9Mixed
Altman Z-Score?11.82Safe
Confidence?68%Moderate
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?9.40%Elevated
Short Interest?14.6M
Days to Cover?3.7
Free Float154.8M
Avg Daily Volume4.0M
Settlement Date2026-05-15
Financial Health
Current Ratio?4.49Strong
Quick Ratio?3.18Strong
Cash Ratio?1.37Strong
Debt/Equity?0.10Low
ValuationRICHLY VALUEDvs 10 peers + S&P 500
Score
50/100
P/E?
Peers
22
S&P
6
72.7PRICEY▾
P/B?
Peers
40
S&P
46
3.82FAIR▾
P/S?
Peers
18
S&P
19
6.58FAIR▾
P/FCF?
Peers
45
S&P
30
29.5FAIR▾
EV/EBITDA?
Peers
27
S&P
9
31.3HIGH▾
EV/Sales?
Peers
18
S&P
23
6.57HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
20
5.3%FAIR▾
ROA?
Peers
44
S&P
39
4.3%FAIR▾
Cash Flow & Enterprise
FCF?$269.6M
Enterprise Value?$8.0B
Fundamentals ratios updated end of day
MarketsMoversWatchlist